国家药监局：支持高端医疗器械创新发展 将出台新措施

Core Viewpoint - The National Medical Products Administration (NMPA) has approved measures to optimize the lifecycle regulation supporting the innovation of high-end medical devices, which is crucial for the development of advanced healthcare technologies [1] Group 1: Regulatory Measures - The approved measures include optimizing special approval procedures and improving classification and naming principles [1] - Continuous enhancement of the standard system and clarification of registration review requirements are part of the initiatives [1] - The measures also focus on strengthening post-market quality and safety monitoring, as well as refining post-market supervision requirements [1] Group 2: Support for Innovation - The initiatives aim to support significant innovations in high-end medical devices, promoting the application of new technologies, materials, processes, and methods in the healthcare sector [1] - The NMPA will enhance coordination, detail relevant requirements, and set clear timelines to ensure smooth implementation of these measures [1]